Nile Life Sciences Private Limited
About Nile Life Sciences Private Limited
Data last updated:
Nile Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 16 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC110310. Its GSTIN is 36AAFCN2901F1ZT (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashanth Ganta and Venakta Padachala Suneetharani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.2 – 58/66 Plot No.66 Sri Sadan Hitex Road Khanamet, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.3 Lakh. For the same year it recorded a net profit of ₹36,401 (net margin 11%) and EBITDA of ₹54,966 (EBITDA margin 16.7%). Revenue has grown at a compounded annual rate (CAGR) of 42% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nile Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.2 – 58/66 Plot No.66 Sri Sadan Hitex Road Khanamet, Hyderabad, Telangana, India – 500084
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Nile Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nile Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nile Life Sciences Private Limited, buy the company report.
Financials of Nile Life Sciences Private Limited
FY 2025 filings availableNile Life Sciences Private Limited reported revenue of ₹3.3 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54,966 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36,401 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.7% | ||||
| Net Profit Margin | 11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nile Life Sciences Private Limited, buy the company report.
Board of directors of Nile Life Sciences Private Limited
Nile Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashanth Ganta | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
| Venakta Padachala Suneetharani Also directs: Nichebit Softech Private Limited | Director | 16 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Nile Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Natural Fillers Private Limited | ₹3.34 Lakh (FY 2024) | 7.0% | Bikaner, Rajasthan, India | |||
| Invertis Pharmaceuticals Private Limited | ₹3.33 Lakh (FY 2024) | -16.0% | Ghaziabad, Uttar Pradesh, India | |||
| Jagosh Pharma Private Limited | ₹3.32 Lakh (FY 2021) | 5988.0% | Kamothe, Maharashtra, India | |||
| Food Script Health Care Private Limited | ₹3.31 Lakh (FY 2021) | Pune, Maharashtra, India | ||||
| Trims Pharma Private Limited | ₹3.3 Lakh (FY 2021) | 213.0% | Navsari, Gujarat, India | |||
| Nile Life Sciences Private Limitedthis company | ₹3.3 Lakh (FY 2024) | ₹36,401 | 11% | Hyderabad, Telangana, India | ||
| Fermac Bio Private Limited | ₹3.3 Lakh (FY 2025) | -56.0% | Medak, Telangana, India | |||
| Ayuraj Industries Private Limited | ₹3.29 Lakh (FY 2024) | 21.0% | Thiruvananthapuram, Kerala, India | |||
| Mount Meru Innovations Private Limited | ₹3.28 Lakh (FY 2023) | Chamarajpet, Karnataka, India | ||||
| Maibiotic Pharmaceuticals Private Limited | ₹3.27 Lakh (FY 2022) | Pune, Maharashtra, India | ||||
| Green Blod Concepts Private Limited | ₹3.27 Lakh (FY 2019) | 86.0% | Mainpuri, Uttar Pradesh, India |
To see the full peer comparison of Nile Life Sciences Private Limited, buy the company report.
Auditor
Nile Life Sciences Private Limited is audited by M A S K AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A S K AND ASSOCIATES | FY 2017 | 014304S |
Shareholding
The shareholding of Nile Life Sciences Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nile Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nile Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nile Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nile Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN2901F1ZT | Telangana | Active | 05 Oct 2017 |
To see the full GST registrations and return filing status of Nile Life Sciences Private Limited, buy the company report.
Recent activity
Nile Life Sciences Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Prashanth Ganta was appointed as Director on 16 Jun 2016.
Frequently asked questions
Nile Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 16 June 2016 (10+ years old) and is registered under CIN U74999TG2016PTC110310.
Nile Life Sciences has 2 current directors:
- Prashanth Ganta - Director
- Venakta Padachala Suneetharani - Director
The latest financial statements of Nile Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Nile Life Sciences is 36AAFCN2901F1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Nile Life Sciences is U74999TG2016PTC110310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nile Life Sciences was incorporated on 16 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nile Life Sciences by revenue are Natural Fillers Private Limited, Invertis Pharmaceuticals Private Limited, Jagosh Pharma Private Limited, Food Script Health Care Private Limited, Trims Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prashanth Ganta was appointed as Director on 16 Jun 2016. Venakta Padachala Suneetharani was appointed as Director on 16 Jun 2016.
The registered office of Nile Life Sciences is at H.No.2 – 5866 Plot No.66 Sri Sadan Hitex Road Khanamet, Hyderabad, Telangana, India – 500084.
Nile Life Sciences operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Nile Life Sciences is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.